Evidence map›Paper›PMID 33789855›Full record

Observational studyBMJ open2021

Multicentre prospective observational study exploring the predictive value of functional echocardiographic indices for early identification of preterm neonates at risk of developing chronic pulmonary hypertension secondary to chronic neonatal lung disease.

Laura Thomas, Michelle Baczynski, Poorva Deshpande, Ashraf Kharrat, Sébastien Joye, Faith Zhu, Daniel Ibarra-Rios, Prakesh S Shah, Luc Mertens, Robert P Jankov and 11 more

Registry-linked trialOpen access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04402645 (Early Identification of Preterm Neonates With Evolving Chronic Pulmonary Hypertension), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04402645 completednot on this map

Early Identification of Preterm Neonates With Evolving Chronic Pulmonary Hypertension: Utility of Functional Echocardiographic Markers

TypeobservationalSponsorMount Sinai Hospital, CanadaRan2017 to 2024Enrolled350ConditionsPulmonary Hypertension, Infant, Premature
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 12 institutions in 6 countries.

Laura ThomasPaediatrics, Sinai Health System, Toronto, Ontario, Canada.
Michelle BaczynskiRespiratory Therapy, Sinai Health System, Toronto, Ontario, Canada.
Poorva DeshpandePaediatrics, Sinai Health System, Toronto, Ontario, Canada.
Ashraf KharratPaediatrics, Sinai Health System, Toronto, Ontario, Canada.
Sébastien JoyeClinic of Neonatology, Lausanne University Hospital, Lausanne, Switzerland.
Faith ZhuPaediatrics, Sinai Health System, Toronto, Ontario, Canada.
Daniel Ibarra-RiosNeonatology, Hospital Infantil de Mexico Federico Gomez, Mexico City, Mexico.
Prakesh S ShahPaediatrics, Sinai Health System, Toronto, Ontario, Canada.
Luc MertensDivision of Cardiology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Robert P JankovDivision of Neonatology, Department of Paediatrics, University of Ottawa, Ottawa, Ontario, Canada.
Xiang Y YeMiCare Research Centre, Sinai Health System, Toronto, Ontario, Canada.
Elaine NearyNeonatology, Liverpool Women's Hospital NHS Foundation Trust, Liverpool, UK.
Joseph TingNeonatology, The University of British Columbia, Vancouver, Ontario, Canada.
Michael CastaldoNeonatology, The University of British Columbia, Vancouver, Ontario, Canada.
Philip LevyBoston Children's Hospital Department of Pediatrics, Boston, Massachusetts, USA.
Aisling SmithNeonatology, Rotunda Hospital, Dublin, Ireland.
Afif F El-KhuffashNeonatology, Rotunda Hospital, Dublin, Ireland.
Regan E GiesingerPediatrics, The University of Iowa Stead Family Children's Hospital, Iowa City, Iowa, USA.
Patrick J McNamaraPediatrics, The University of Iowa Stead Family Children's Hospital, Iowa City, Iowa, USA.
Dany E WeiszNewborn and Developmental Paediatrics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Amish JainPaediatrics, Sinai Health System, Toronto, Ontario, Canada amish.jain@sinaihealth.ca.ORCID http://orcid.org/0000-0002-1413-2966
University of Toronto · CASinai Health System · CARotunda Hospital · IESunnybrook Health Science Centre · CAUniversity of British Columbia · CAUniversity of Iowa Stead Family Children’s Hospital · USBoston Children's Hospital · USHospital for Sick Children · CAHospital Infantil de México Federico Gómez · MXUniversity of Lausanne · CHUniversity of Liverpool · GBUniversity of Ottawa · CA

Funding

CIHR 154860
6 · The paper itself

Abstract

introductionAlthough chronic pulmonary hypertension (cPH) secondary to chronic neonatal lung disease is associated with increased mortality and respiratory and neurodevelopmental morbidities, late diagnosis (typically ≥36 weeks postmenstrual age, PMA) and the use of qualitative echocardiographic diagnostic criterion (flat interventricular septum in systole) remain significant limitations in clinical care. Our objective in this study is to evaluate the utility of relevant quantitative echocardiographic indices to identify cPH in preterm neonates, early in postnatal course and to develop a diagnostic test based on the best combination of markers. METHODS AND ANALYSIS: In this ongoing international prospective multicentre observational diagnostic accuracy study, we aim to recruit 350 neonates born <27 weeks PMA and/or birth weight <1000 g and perform echocardiograms in the third week of age and at 32 weeks PMA (early diagnostic assessments, EDA) in addition to the standard diagnostic assessment (SDA) for cPH at 36 weeks PMA. Predefined echocardiographic markers under investigation will be measured at each EDA and examined to create a scoring system to identify neonates who subsequently meet the primary outcome of cPH/death at SDA. Diagnostic test characteristics will be defined for each EDA. Pulmonary artery acceleration time and tricuspid annular plane systolic excursion are the primary markers of interest. ETHICS AND DISSEMINATION: Ethics approval has been received by the Mount Sinai Hospital Research Ethics Board (REB) (#16-0111-E), Sunnybrook Health Sciences Centre REB (#228-2016), NHS Health Research Authority (IRAS 266498), University of Iowa Human Subjects Office/Institutional Review Board (201903736), Rotunda Hospital Research and Ethics Committee (REC-2019-008), and UBC Children's and Women's REB (H19-02738), and is under review at Boston Children's Hospital Institutional Review Board. Study results will be disseminated to participating families in lay format, presented to the scientific community at paediatric and critical care conferences and published in relevant peer-reviewed journals. TRAIL REGISTRATION NUMBER: NCT04402645.

Indexed as

Hypertension, PulmonaryLung DiseasesBostonChildEchocardiographyFemaleHumansInfantInfant, NewbornProspective Studiesechocardiographyneonatal intensive & critical carepaediatric cardiology

Identifiers

PMID33789855
PMCPMC8016080
OpenAlexW3140919212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.